http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104911150-B

Outgoing Links

Predicate Object
classificationIPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12R1-91
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-577
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-569
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-42
filingDate 2015-05-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2018-05-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2018-05-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-104911150-B
titleOfInvention The foundation of monoclonal antibody hybridoma cell strain and its preparation and application of monoclonal antibody of a kind of H3N2 canine influenza virus
abstract The present invention relates to cell engineering field, discloses the foundation of monoclonal antibody hybridoma cell strain and its preparation and application of monoclonal antibody of a kind of H3N2 canine influenza virus.The hybridoma cell strain is deposited in China typical culture collection center on May 13rd, 2015, and deposit number is CCTCC C201555;Its monoclonal antibody secreted is specifically bound with H3N2 hypotype canine influenza virus hemagglutinin, and affinity is high, and potency is 1 after purification:320,000, it does not react with CDV, CPV, CPIV, CAV II, CRV and H7N9, H10N8, H9N2 subtype influenza virus.The infection for preventing and controlling influenza virus by injecting monoclonal antibody of the present invention to be used for, compared with traditional vaccine inoculation means, specificity is stronger, and risk is lower, security higher.With actual application value.
priorityDate 2015-05-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451186576
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP13840
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID448573
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ9INJ1
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID10095
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCO70695
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP36285
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419485251
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID11309
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID61365
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP89681
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP36284
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP54635
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP27405
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP27404
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID37610
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP11333
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCW6JHZ8
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10635
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP27406
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ9G059
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCO72120
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID11309
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID10095
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID37610
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP0DOK3
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCD1MEI6
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP19192
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419506651

Total number of triples: 44.